Latest Financial Position News

Lykos Metals Limited reports significant high-grade mineral findings at its Sinjakovo Project and extends its Jezero exploration permit, alongside key board appointments and cost restructuring.

Accent Resources NL reports solid progress in its Magnetite Range and Norseman Gold projects during Q4 2024, supported by a robust cash position of $10.64 million. Key exploration milestones and new tenement applications set the stage for an active 2025.

BOA Resources Limited reveals its strategic drilling plans for 2025 targeting key lithium and nickel tenements in Western Australia, alongside a refreshed board and ongoing asset optimisation.

Corella Resources reports promising rare earth element drilling results at its Tampu Project alongside significant board and management changes, while facing tight cash reserves.

Energy Technologies Limited reported a 17.5% increase in unaudited sales revenue for 2Q FY2025, driven by a new cable supply contract and a robust order book, signaling positive momentum amid a strategic business plan revision.

Tambourah Metals reports significant high-grade gold assay results from its Pilbara projects and secures government grants to accelerate drilling programs across multiple prospects.

Bass Oil Limited reported a 27% drop in quarterly revenue amid natural production declines but highlighted promising developments in its Kiwi gas field project in the Cooper Basin.

Manhattan Corporation has secured a pivotal Farm-In Agreement with Novo Resources for its Tibooburra Gold Project and gained surface access to progress drilling at its Chebogue Lithium Project in Canada, underpinning its exploration ambitions.

Alvo Minerals reports a 7.2Mt copper-equivalent resource at Palma and promising rare earth element drill results at Ipora, while launching a contracting division to offset costs.

NOVONIX has advanced its position in the battery materials sector with a conditional US$754 million loan commitment from the U.S. Department of Energy and binding offtake agreements with automotive giants Stellantis and PowerCo. These milestones underpin its expansion plans for synthetic graphite production in North America.

Clarity Pharmaceuticals reports robust progress in its SECURE trial and secures FDA Fast Track Designation for its diagnostic agent 64Cu-SAR-bisPSMA, underpinning its growth and innovation in prostate cancer treatment.

Ark Mines Ltd reported a significant cash outflow in its December 2024 quarter, prompting plans for a capital raising to support ongoing exploration activities.